We are live on ! Find out more
Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $19.7B
1-Year Est. Return 39.39%
This Fund
S&P 500
This Quarter Est. Return
+17.95%
1 Year Est. Return
+39.39%
3 Year Est. Return
+109.64%
5 Year Est. Return
+114.77%
10 Year Est. Return
+339.3%
AUM
$19.7B
AUM Growth
+$4.27B
Cap. Flow
+$1.78B
Cap. Flow %
9.02%
Top 10 Hldgs %
24.77%
Holding
2,672
New
452
Increased
653
Reduced
572
Closed
618

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.51%
2 Financials 11.55%
3 Technology 7.51%
4 Industrials 6.91%
5 Consumer Discretionary 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RZLV
1151
PUT
Rezolve AI
RZLV
$946M
$1.64M 0.01%
+520,600
New +$1.37M
NUE icon
1152
Nucor
NUE
$56.4B
$1.63M 0.01%
7,335
-9,867
-57% -$2.23M
PTCT icon
1153
CALL
PTC Therapeutics
PTCT
$5.46B
$1.63M 0.01%
+20,000
New +$1.44M
RXRX icon
1154
PUT
Recursion Pharmaceuticals
RXRX
$2.05B
$1.62M 0.01%
441,400
+35,700
+9% +$119K
DYNC
1155
Dynamix Corp
DYNC
$241M
$1.62M 0.01%
+150,000
New +$1.61M
VEEV icon
1156
CALL
Veeva Systems
VEEV
$42.1B
$1.61M 0.01%
9,100
T icon
1157
PUT
AT&T
T
$174B
$1.6M 0.01%
77,400
-2,500
-3% -$62K
JEF icon
1158
Jefferies Financial Group
JEF
$11B
$1.6M 0.01%
31,914
+25,742
+417% +$1.33M
COST icon
1159
PUT
Costco
COST
$397B
$1.59M 0.01%
1,700
-2,400
-59% -$2.39M
CME icon
1160
CALL
CME Group
CME
$99.2B
$1.59M 0.01%
7,200
ESPR
1161
DELISTED
Esperion Therapeutics
ESPR
$1.59M 0.01%
+502,200
New +$1.4M
PG icon
1162
PUT
Procter & Gamble
PG
$340B
$1.58M 0.01%
10,800
+4,500
+71% +$655K
HAYW icon
1163
Hayward Holdings
HAYW
$2.76B
$1.58M 0.01%
91,410
+39,632
+77% +$579K
EGBN icon
1164
Eagle Bancorp
EGBN
$863M
$1.58M 0.01%
55,726
-27,486
-33% -$736K
CBOE icon
1165
Cboe Global Markets
CBOE
$28.5B
$1.58M 0.01%
+6,495
New +$1.99M
CI icon
1166
PUT
Cigna
CI
$72.7B
$1.57M 0.01%
5,700
+3,100
+119% +$876K
NVS icon
1167
CALL
Novartis
NVS
$267B
$1.57M 0.01%
+10,000
New +$1.5M
NVS icon
1168
Novartis
NVS
$267B
$1.57M 0.01%
10,000
+7,140
+250% +$1.07M
CORZ icon
1169
Core Scientific
CORZ
$5.78B
$1.57M 0.01%
61,185
-293,674
-83% -$6.91M
PFE icon
1170
CALL
Pfizer
PFE
$158B
$1.56M 0.01%
64,800
+3,100
+5% +$81.1K
KSS icon
1171
Kohl's
KSS
$1.88B
$1.56M 0.01%
87,830
+37,206
+73% +$552K
HLT icon
1172
CALL
Hilton Worldwide
HLT
$68.8B
$1.55M 0.01%
4,700
-100
-2% -$32.9K
XLY icon
1173
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.1B
$1.55M 0.01%
13,200
-19,900
-60% -$2.32M
OI icon
1174
O-I Glass
OI
$933M
$1.54M 0.01%
+160,000
New +$1.51M
SVAC
1175
DELISTED
Spring Valley Acquisition Corp III
SVAC
$1.54M 0.01%
150,000
-140,000
-48% -$1.46M

Similar funds

Verition Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, Verition Fund Management held 2,672 positions worth $19.7B, up 28% from $15.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Verition Fund Management deployed $1.78B of net new capital in Q2 2026, opening 452 new positions and adding to 653 existing holdings. Its largest new stake was Select Medical: 12,025,235 shares worth $199M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 44% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Old National Bancorp, an estimated $63M trimmed.

  • Verition Fund Management's largest Q2 2026 buy was Select Medical: 12,025,235 shares worth $199M.
  • Verition Fund Management added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $1.09B increase.
  • Verition Fund Management's biggest Q2 2026 reduction was Old National Bancorp, cutting an estimated $63M.
  • Verition Fund Management fully exited Brown & Brown in Q2 2026, selling an estimated $70.9M.
  • Verition Fund Management's ten largest holdings make up 25% of its $19.7B portfolio in Q2 2026.
  • Verition Fund Management opened 452 new positions and closed 618 in Q2 2026.
  • Verition Fund Management's portfolio value rose 28% quarter-over-quarter to $19.7B.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.